End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
2.73
CNY
|
0.00%
|
|
+1.87%
|
-21.78%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
13,838
|
13,679
|
6,545
|
4,044
|
6,349
|
4,021
|
Enterprise Value (EV)
1 |
14,686
|
14,968
|
9,300
|
6,813
|
9,067
|
6,258
|
P/E ratio
|
80.2
x
|
43.4
x
|
660
x
|
-3.14
x
|
-5.01
x
|
-3.26
x
|
Yield
|
0.13%
|
0.23%
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
6.7
x
|
4.26
x
|
1.97
x
|
1.8
x
|
4.77
x
|
4.11
x
|
EV / Revenue
|
7.11
x
|
4.66
x
|
2.8
x
|
3.03
x
|
6.81
x
|
6.39
x
|
EV / EBITDA
|
42.5
x
|
27.9
x
|
26.9
x
|
54.9
x
|
-86.2
x
|
-12.7
x
|
EV / FCF
|
-26
x
|
-19.6
x
|
-48.5
x
|
331
x
|
27.3
x
|
12.1
x
|
FCF Yield
|
-3.85%
|
-5.1%
|
-2.06%
|
0.3%
|
3.67%
|
8.28%
|
Price to Book
|
4.15
x
|
2.66
x
|
1.33
x
|
1.11
x
|
2.66
x
|
3.49
x
|
Nbr of stocks (in thousands)
|
1,006,433
|
1,151,399
|
1,152,215
|
1,152,215
|
1,152,215
|
1,152,215
|
Reference price
2 |
13.75
|
11.88
|
5.680
|
3.510
|
5.510
|
3.490
|
Announcement Date
|
2/27/18
|
4/22/19
|
4/29/20
|
4/28/21
|
4/27/22
|
4/28/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
2,064
|
3,214
|
3,322
|
2,247
|
1,332
|
978.8
|
EBITDA
1 |
345.2
|
537.2
|
346.2
|
124
|
-105.1
|
-494.3
|
EBIT
1 |
225.5
|
390.3
|
146.1
|
-69.18
|
-303.8
|
-618.4
|
Operating Margin
|
10.92%
|
12.15%
|
4.4%
|
-3.08%
|
-22.8%
|
-63.19%
|
Earnings before Tax (EBT)
1 |
184.1
|
354
|
-7.089
|
-1,334
|
-1,340
|
-1,252
|
Net income
1 |
172.5
|
301.1
|
9.881
|
-1,290
|
-1,268
|
-1,233
|
Net margin
|
8.36%
|
9.37%
|
0.3%
|
-57.39%
|
-95.2%
|
-125.96%
|
EPS
2 |
0.1715
|
0.2740
|
0.008600
|
-1.119
|
-1.101
|
-1.070
|
Free Cash Flow
1 |
-564.8
|
-764
|
-191.6
|
20.61
|
332.7
|
518.1
|
FCF margin
|
-27.36%
|
-23.77%
|
-5.77%
|
0.92%
|
24.98%
|
52.93%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
16.62%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0175
|
0.0270
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/27/18
|
4/22/19
|
4/29/20
|
4/28/21
|
4/27/22
|
4/28/23
|
Fiscal Period: December |
2022 Q1
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
-90.18
|
Net margin
|
-
|
EPS
2 |
-0.0783
|
Dividend per Share
|
-
|
Announcement Date
|
4/27/22
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
848
|
1,289
|
2,755
|
2,768
|
2,718
|
2,237
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.456
x
|
2.399
x
|
7.958
x
|
22.32
x
|
-25.85
x
|
-4.526
x
|
Free Cash Flow
1 |
-565
|
-764
|
-192
|
20.6
|
333
|
518
|
ROE (net income / shareholders' equity)
|
4.96%
|
6.72%
|
-0.02%
|
-30.6%
|
-42.5%
|
-69.9%
|
ROA (Net income/ Total Assets)
|
2.2%
|
3%
|
0.96%
|
-0.5%
|
-2.71%
|
-6.98%
|
Assets
1 |
7,835
|
10,023
|
1,034
|
258,170
|
46,833
|
17,664
|
Book Value Per Share
2 |
3.310
|
4.470
|
4.280
|
3.170
|
2.070
|
1.000
|
Cash Flow per Share
2 |
1.400
|
1.400
|
0.3900
|
0.1300
|
0.0200
|
0.0300
|
Capex
1 |
455
|
882
|
264
|
113
|
24
|
20.8
|
Capex / Sales
|
22.05%
|
27.44%
|
7.94%
|
5.05%
|
1.8%
|
2.13%
|
Announcement Date
|
2/27/18
|
4/22/19
|
4/29/20
|
4/28/21
|
4/27/22
|
4/28/23
|
|
1st Jan change
|
Capi.
|
---|
| -21.78% | 434M | | +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.24B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +16.93% | 14.96B | | +7.73% | 15.03B |
Other Commodity Chemicals
|